Vimarsana
Biggest News Aggregation in the World

Page 32 - Oint Inflammation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oint Inflammation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oint Inflammation Today - Breaking & Trending Today

Psoriasis and PsA Show Distinctive Skin Microbiomes - Vimarsana News

Psoriasis and PsA Show Distinctive Skin Microbiomes

No significant microbiome differences were noted between lesional and nonlesional skin swab samples from patients with psoriasis and psoriatic arthritis.

Cardio-Rheumatology Clinics Guide Care for Unique Population - Vimarsana News

Cardio-Rheumatology Clinics Guide Care for Unique Population

Cardio-rheumatology programs are "the newest child" in a series of cardiology offshoots. Such clinics aim to prevent and manage complex cardiovascular conditions in rheumatology patients.

Best Estimates Made for Hydroxychloroquine Retinopathy Risk - Vimarsana News

Best Estimates Made for Hydroxychloroquine Retinopathy Risk

Hydroxychloroquine dosing and retinopathy risk have long been a concern with its use. A new, comprehensive study finds that retinopathy diagnosis with cumulative dosing is actually low.

Drugs Advertised on TV Aren't Better Than Existing Options: Study - Vimarsana News

Drugs Advertised on TV Aren't Better Than Existing Options: Study

Manufacturers spend more on advertising for those less beneficial drugs than for ones that work better.

Two Novel JAK Inhibitors Show Promise in Ulcerative Colitis - Vimarsana News

Two Novel JAK Inhibitors Show Promise in Ulcerative Colitis

Ritlecitinib and brepocitinib were both more effective than placebo with acceptable safety in a phase 2b study of patients with moderate to severe ulcerative colitis.